Skip to content

Prospective Multicenter Study to Characterize the REAL-WORLD EVIDENCE Regarding Safety and Performance of the PTCA Catheters Family

Prospective Multicenter Study to Characterize the REAL-WORLD EVIDENCE Regarding Safety and Performance of the PTCA Catheters Family

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05232565
Enrollment
60
Registered
2022-02-10
Start date
2022-07-29
Completion date
2023-07-15
Last updated
2023-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Stenosis

Brief summary

The purpose of this Post market Study is to collect clinical data of the Arthesys PTCA catheters family during angioplasty intervention of coronary vessels or coronary bypass graft stenosis to support MDR submission.

Interventions

PROCEDUREPercutaneous Transluminal Coronary Angioplasty

Angioplasty intervention of coronary vessels or coronary bypass graft stenosis

Sponsors

Arthesys
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with a Percutaneous intervention to a native coronary or coronary bypass graft indication * Patient \>18 years * Patient who understands the trial requirements and the treatment procedures and provides written informed consent

Exclusion criteria

\- Patients will not be included if they are under judicial protection, guardianship or curatorship or if they are deprived of their liberty by judicial or administrative decision.

Design outcomes

Primary

MeasureTime frameDescription
Efficacy endpointUp to end of PTCA procedureBalloon successfully reaching and crossing target location, successful inflation, deflation, and retrieval in the guiding catheter
Safety endpointUp to end of PTCA procedureSuccessful balloon dilatation without device related adverse event during the dilatation procedure

Secondary

MeasureTime frameDescription
Performance - pre-dilatationUp to end of PTCA procedureResidual stenosis \< 50% and TIMI flow grade 3
Performance - post-dilatationUp to end of PTCA procedureAngiographic success of the device defined as \<30% residual stenosis after angiography

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026